ScholarWorks@Korea University College of Medicine

Gynecologic Oncology

Journal Title

  • Gynecologic Oncology

ISSN

  • E 1095-6859 | P 0090-8258 | 1095-6859 | 0090-8258

Publisher

  • Academic Press
  • Elsevier

Listed on(Coverage)

JCR1997-2019
SJR1999-2019
CiteScore2011-2019
SCI2010-2019
SCIE2010-2021
CC2016-2021
SCOPUS2017-2020
MEDLINE2016-2021
EMBASE2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: /// Cell and molecular biology /// Chemotherapy /// Cytology /// Endocrinology /// Epidemiology /// Genetics /// Gynecologic surgery /// Immunology /// Pathology /// Radiotherapy

Homepage

Article List

1 - 20 out of 39 results.

SCIESCOPUS
Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R)

Kim, Se Ik; Nam, So Hyun; Hwangbo, Suhyun; Kim, Yeorae; Cho, Hyun-Woong; Suh, Dong Hoon; Song, Jae Yun; Kim, Jae-Weon; Choi, Chel Hun; Kim, Dae-Yeon, et al.

ArticleIssue Date2023CitationGynecologic Oncology, v.173, pp.88 - 97PublisherAcademic Press
SCIESCOPUS
Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor

McNamara, Blair; Harold, Justin; Manavella, Diego; Bellone, Stefania; Mutlu, Levent; Hartwich, Tobias Max Philipp; Zipponi, Margherita; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z., et al.

ArticleIssue Date2023CitationGynecologic Oncology, v.172, pp.65 - 71PublisherAcademic Press
SCIESCOPUS
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma (vol 168, pg 157, 2023)

Harold, Justin; Bellone, Stefania; Manavell, Diego D.; Mutlu, Levent; McNamara, Blair; Hartwich, Tobias Max Philipp; Zipponi, Margherita; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler Z., et al.

ArticleIssue Date2023CitationGynecologic Oncology, v.170PublisherAcademic Press
SCIESCOPUS
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor

Manavella, Diego D.; McNamara, Blair; Harold, Justin; Bellone, Stefania; Hartwich, Tobias Max Philipp; Yang-Hartwich, Yang; Mutlu, Levent; Zipponi, Margherita; Demirkiran, Cem; Verzosa, Miguel Skyler, et al.

ArticleIssue Date2023CitationGynecologic Oncology, v.169, pp.98 - 105PublisherAcademic Press
SCIESCOPUS
Does endometriosis increase the risks of endometrial hyperplasia and endometrial cancer?

Kim, Hoon; Kim, Hyun Jung; Ahn, Hyeong Sik

ArticleIssue Date2023CitationGynecologic Oncology, v.169, pp.147 - 153PublisherAcademic Press
SCOPUS
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma

Harold, Justin; Bellone, Stefania; Manavella, Diego D.; Mutlu, Levent; McNamara, Blair; Hartwich, Tobias Max Philipp; Zipponi, Margherita; Yang-Hartwich, Yang; Demirkiran, Cem; Verzosa, Miguel Skyler, et al.

ArticleIssue Date2023CitationGynecologic Oncology, v.168, pp.157 - 165PublisherAcademic Press
SCIESCOPUS
Corrigendum to: "Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer"

Shim, Jung-In; Ryu, Ji-Yoon; Jeong, Soo Young; Cho, Young-Jae; Choi, Jung-Joo; Hwang, Jae Ryoung; Choi, Ju-Yeon; Sa, Jason K.; Lee, Jeong-Won

ArticleIssue Date2022CitationGynecologic Oncology, v.166, no.2, pp.370 - 371PublisherAcademic Press
SCIESCOPUS
Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor

Tymon-Rosario, Joan R.; Manara, Paola; Manavella, Diego D.; Bellone, Stefania; Hartwich, Tobias Max Philipp; Harold, Justin; Yang-Hartwich, Yang; Zipponi, Margherita; Choi, Jungmin; Jeong, Kyungjo, et al.

ArticleIssue Date2022CitationGynecologic Oncology, v.166, no.1, pp.117 - 125PublisherAcademic Press
SCIESCOPUS
Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer

Shim, Jung-In; Ryu, Ji-Yoon; Jeong, Soo Young; Cho, Young-Jae; Choi, Jung-Joo; Hwang, Jae Ryoung; Choi, Ju-Yeon; Sa, Jason K.; Lee, Jeong-Won

ArticleIssue Date2022CitationGynecologic Oncology, v.165, no.2, pp.270 - 280PublisherAcademic Press
SCIESCOPUS
Ultrasonographic evaluation of ovarian mass for predicting malignancy in pregnant women

Lee, Se Jin; Kim, Young-Han; Lee, Mi-Young; Ko, Hyun Sun; Oh, Soo-young; Seol, Hyun-Joo; Kim, Jong Woon; Ahn, Ki Hoon; Na, Sunghun; Seong, Won Joon, et al.

ArticleIssue Date2021CitationGynecologic Oncology, v.163, no.2, pp.385 - 391PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
SCIESCOPUS
Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer

Shim, S.-H.; Chae, S.H.; So, K.A.; Lee, S.J.; Lee, J.Y.; Kim, T.J.; Han, E.S.; Kang, S.-B.

ArticleIssue Date2021CitationGynecologic Oncology, v.161, no.3, pp.810 - 816PublisherAcademic Press Inc.
Magnetic resonance imaging for differentiating ovarian endometrioid carcinoma from clear cell carcinoma

Kim, Kyeong Ah

ConferenceIssue Date2020CitationSGO 2020 Annual Meeting on Women's Cancer , pp.334 - 335PublisherACADEMIC PRESS INC ELSEVIER SCIENCEPlaceUS; Toronto, Canada
Seromucinous tumors of ovary: Computed tomographic and magnetic resonance imaging features

Kim, Kyeong Ah

ConferenceIssue Date2020CitationSGO 2020 Annual Meeting on Women's Cancer, pp.343PublisherACADEMIC PRESS INC ELSEVIER SCIENCEPlaceUS; Toronto, Canada
Risk of occult atypical hyperplasia or cancer in women with non-atypical endometrial hyperplasia

Nara Lee; Kwang‐Beom Lee; Kidong Kim; Jin Hwa Hong; Ga Won Yim; Seok Ju Seong; Banghyun Lee; Jong‐Min Lee; Soyi Lim; Yung‐Taek Ouh, et al.

ConferenceIssue Date2020Citation51st Annual Meeting of the Society of Gynecologic Oncology, pp.217PublisherACADEMIC PRESS INC ELSEVIER SCIENCEPlaceUS; webinars
SCIESCOPUS
Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy

Kim, Hakyoung; Cho, Won Kyung; Kim, Yeon Joo; Kim, Young Seok; Park, Won

ArticleIssue Date2020CitationGynecologic Oncology, v.157, no.2, pp.423 - 428PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
SCIESCOPUS
The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN)

Cho, Hyun-Woong; Ouh, Yung-Taek; Min, Kyung-Jin; Lee, Nak Woo; Lee, Sanghoon; Song, Jae Yun; Hong, Jin Hwa; Lee, Jae Kwan

ArticleIssue Date2020CitationGynecologic Oncology, v.156, no.3, pp.606 - 610PublisherAcademic Press
CXCL1 mediates adiponectin-induced angiogenesis in ovarian cancer

Ouh, Y. T.; Lee, Y. J.; Cho, H. W.; Lee, J. K.; Hong, J. H.

ConferenceIssue Date2019Citation50th Annual Meeting of the Society of Gynecologic Oncology, pp.101 - 102PublisherSociety of Gynecologic Oncology (SGO)PlaceUS; Honolulu, HI, USA
SCIESCOPUS
A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17)

Yoon, Mee Sun; Park, Won; Huh, Seung Jae; Kim, Hak Jae; Kim, Young Seok; Kim, Yong Bae; Kim, Joo-Young; Lee, Jong-Hoon; Kim, Hun Jung; Cha, Jihye, et al.

ArticleIssue Date2015CitationGYNECOLOGIC ONCOLOGY, v.138, no.3, pp.519 - 525PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
ASC-US and LSIL triage in Korean women: Revisiting the 2012 ASCCP screening guidelines

Min, K. J.; Yang, S. Y.; Koo, Y. J.; Hong, J. H.; Lee, J. K.

ConferenceIssue Date2015Citation46th ANNUAL MEETING ON WOMEN’S CANCER, pp.72PublisherACADEMIC PRESS INC ELSEVIER SCIENCEPlaceUS
SCIESCOPUS
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10

Hong, Sook Hee; Lee, Soohyeon; Kim, Hoon-Gu; Lee, Hyo Jin; Jung, Kyung Hae; Lee, Sang-Cheol; Lee, Na-Ri; Yun, Jina; Woo, In Sook; Park, Kyong Hwa, et al.

ArticleIssue Date2015CitationGYNECOLOGIC ONCOLOGY, v.136, no.2, pp.212 - 217PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
1 2
STATISTICS
Total View :10,903,636
Today View :4,490

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어